2024
|
Invention
|
Process for preparing mavacamten and process intermediate. A process for preparing the Pharmaceut... |
|
Invention
|
Solvated form of trilaciclib dihydrochloride. The present invention refers to the technical field... |
|
Invention
|
Process for preparing pralsetinib, and intermediates thereof in crystalline form. The present inv... |
|
Invention
|
Process for preparing pralsetinib in amorphous form. Process for preparing Pralsetinib in amorpho... |
|
Invention
|
Process for preparing trilaciclib or a salt thereof. Process for the preparation of trilaciclib h... |
|
Invention
|
Crystalline aceclidine hcl hemihydrate and processes for preparing the same. A crystalline Acecli... |
2023
|
Invention
|
Process for preparing zanubrutinib. Process for preparing Zanubrutinib, wherein the intermediate ... |
|
Invention
|
Method and assembly for the control of the formation of a nitrosamine impurity in a solid active ... |
|
Invention
|
Purification process of rifampicin from nitrosamines. The present invention relates to the contro... |
|
Invention
|
Process for preparing zanubrutinib in amorphous form. The present invention relates to a Process ... |
2022
|
Invention
|
Process for the preparation of zanubrutinib.
It is described a process for the preparation of Za... |
|
Invention
|
Process for the preparation of zanubrutinib. It is described a process for the preparation of Zan... |
|
Invention
|
Process for preparing high purity degree larotrectinib.
A process for preparing Larotrectinib su... |
|
Invention
|
Process for preparing high purity degree larotrectinib. The present invention relates to a Larotr... |
2021
|
Invention
|
Process for the preparation of a key intermediate of siponimod.
The present invention relates to... |
|
Invention
|
Process for the preparation of a key intermediate of siponimod. The present invention relates to ... |
|
Invention
|
Process for the preparation of an intermediate used in the synthesis of letermovir. S44 on the im... |
|
Invention
|
Novel crystalline compound of siponimod hemifumarate.
The present invention relates to a novel c... |
|
Invention
|
Novel crystalline compound of siponimod hemifumarate. The present invention relates to a novel cr... |
|
Invention
|
Novel crystalline compound of vadadustat. The present invention relates to a novel crystalline co... |
2020
|
Invention
|
Process for the preparation of lasmiditan and of a synthesis intermediate.
A process for the pre... |
|
Invention
|
Process for the preparation of lasmiditan and of a synthesis intermediate. The present invention ... |
|
Invention
|
Stable crystalline apalutamide in pure form, and process for the preparation thereof.
The presen... |
|
Invention
|
Stable crystalline apalutamide in pure form, and process for the preparation thereof. The present... |
|
Invention
|
Process for the preparation of crisaborole in a stable crystal form. The present invention relate... |
|
Invention
|
Synthesis of stable amorphous apalutamide.
The present invention relates to a process for the pr... |
|
Invention
|
Synthesis of stable amorphous apalutamide. The present invention relates to a process for the pre... |
2019
|
Invention
|
Process for the preparation of lifitegrast. 6 alkyl groups; b) chlorination of compound (IV) in t... |
|
Invention
|
Process for the preparation of lifitegrast. 123166 alkyl groups; b) chlorination of compound (IV)... |
|
Invention
|
Process for the preparation of lifitegrast. The invention relates to a process for the preparatio... |
|
Invention
|
Process for the preparation of apalutamide. The present invention relates to a process for the pr... |
|
Invention
|
Method for the preparation of pimavanserin base. Disclosed is a process for the synthesis of pima... |
|
Invention
|
Process for the synthesis of optically active beta-amino alcohols.
Subject-matter of the present... |
|
Invention
|
Process for the synthesis of optically active beta-amino alcohols. Subject-matter of the present ... |
|
Invention
|
Crystalline forms of venetoclax.
Disclosed are new crystalline forms of venetoclax, a selective ... |
2018
|
Invention
|
Process for preparing intermediates for the synthesis of optically active beta-amino alcohols by ... |
|
Invention
|
Efficient method for the preparation of cangrelor. Disclosed is a process for the preparation of ... |
|
Invention
|
Amorphous form of pimavanserin hemitartrate.
Disclosed is the amorphous form of pimavanserin* he... |
|
P/S
|
Active chemical ingredients for use in the manufacture of
pharmaceuticals. |
|
P/S
|
Active chemical ingredients for use in the manufacture of pharmaceuticals, namely, antineoplastic... |
|
P/S
|
Active chemical ingredients for use in the manufacture of pharmaceuticals. |
|
Invention
|
A process for the preparation of crisaborole.
The present invention relates to a process for the... |
|
Invention
|
Process for the preparation of a novel umeclidinium synthesis intermediate. The present invention... |
2015
|
P/S
|
Chemicals and chemical substances for use in the food processing, pharmaceutical, chemical and ag... |
2010
|
P/S
|
Active principles, raw materials and chemical products for
the pharmaceutical industry; pharmace... |